在心脏代谢疾病中,对VLDL生成的分子调节和治疗向
Kendall H Burks1, Nathan O Stitziel1, Nicholas O Davidson2
1Division of Cardiology, Department of Medicine, Center for Cardiovascular Research, Washington University School of Medicine, Saint Louis, Missouri.
Cellular and molecular gastroenterology and hepatology
|October 15, 2024
概括
与代谢功能障碍相关的脂肪性肝病 (MASLD) 与动脉样硬化心血管疾病 (CVD) 有关. 在MASLD中失调的非常低密度脂蛋白 (VLDL) 生产有助于心血管疾病风险,提供治疗点.
科学领域:
- 心脏病学 心脏病学
- 肝病学 肝病学是一种肝病学.
- 代谢疾病 代谢疾病
背景情况:
- 心血管疾病 (CVD) 是患有脂肪性肝病 (SLD) 的患者的主要死亡原因,特别是与代谢功能障碍相关的SLD (MASLD).
- 胰岛素耐药性在MASLD中很常见,并且与心血管疾病的发病有关.
- 非常低密度脂蛋白 (VLDL) 在心血管疾病发展中起着关键作用,特别是在代谢功能障碍患者中.
研究的目的:
- 在MASLD和动脉样硬化心血管疾病的背景下审查VLDL的临床意义.
- 探索针对心脏代谢疾病中的VLDL代谢的转化和治疗潜力.
主要方法:
- 目前临床证据和关于SLD和CVD中VLDL代谢的研究的审查.
- 分析胰岛素抵抗在VLDL产生和分泌中的作用.
- 检查VLDL组装,成熟,代谢和清除途径.
主要成果:
- 在MASLD中,VLDL的产生因肥胖症和胰岛素耐药性而失调.
- 胰岛素耐药性影响着VLDL的产生和动脉样硬化心血管疾病的发展.
- 在心脏代谢疾病中,VLDL的聚集和分泌是关键途径.
结论:
- 针对VLDL代谢为患有MASLD和心血管疾病风险增加的患者提供了潜在的治疗策略.
- 了解VLDL的作用对于管理复杂患者群体中的心脏代谢风险至关重要.
- 在VLDL代谢中的关键调节步骤为干预提供了可行的目标.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
579
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
579
Regulation of Metabolism
9.3K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.3K
Cholesterol: Significance and Regulation
518
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
518
Coronary Artery Disease IV: Medical Management
4
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
4
Overview of Lipid Metabolism
1.1K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.1K
Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2


